Not logged in.png)
Share.png)
SaveA Hybrid Transformer-Graph Model for Multi-Class Lymph Node Segmentation in Histopathology
Budginaite, Elzbieta; Magee, Derek R.; Kloft, Maximilian; Nankivell, Matthew; Langley, Ruth E.; Cunningham, David; Allum, William H.; Raghuram, Gayatri; Yoshikawa, Takaki; Oshima, Takashi; Woodruff, Henry C.; Grabsch, Heike, I Share Save Share Save Share Save Share Save Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resectionKawahara, S.; Aoyama, T.; Murakawa, M.; Kanemoto, R.; Matsushita, N.; Hashimoto, I.; Maezawa, Y.; Kamiya, M.; Kobayashi, S.; Ueno, M.; Yamamoto, N.; Oshima, T.; Yukawa, N.; Saito, A.; Morinaga, S. Share Save Neoadjuvant and adjuvant pembrolizumab (pembro) plus chemotherapy (chemo) for locally advanced gastric or gastroesophageal junction (G/GEJ) cancer: Patient-reported outcomes (PROs) from the phase III KEYNOTE-585 studyShitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y-K.; Al-Batran, S-E.; Yoshikawa, T.; Weber, P. E. Yanez; Di Bartolomeo, M.; Lonardi, S.; Guan, Y.; Valderrama, A.; Shih, C-S.; Fang, X.; Bang, Y-J. Share Save Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancerShitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y-K.; Al-Batran, S-E.; Yoshikawa, T.; Weber, P. E. Yanez; Di Bartolomeo, M.; Lonardi, S.; Fang, X.; Shih, C-S.; Bhagia, P.; Bang, Y-J. Share Save Share Save Share Save Share Save Phase (ph) Ib results of bemarituzumab (BEMA) added to capecitabine/oxaliplatin (CAPOX) or S-1/oxaliplatin (SOX) with or without nivolumab (NIVO) for previously untreated advanced gastric/gastroesophageal junction cancer (G/ GEJC): FORTITUDE-103 studyLee, K-W.; Kang, Y-K.; Chen, M-H.; Hirano, H.; Sunakawa, Y.; Kim, S. T.; Lin, C-C.; Yong, W. P.; Kawakami, T.; Oshima, T.; Li, Z.; Hopkins, M.; Levin, A.; Wang, H.; Goldstein, L.; Zhou, D.; Rha, S. Y. Share Save Claudin 18.2 expression in resected gastric cancerFuruta, M.; Hiroshima, Y.; Sato, S.; Oonishi, M.; Hama, T.; Furusawa, K.; Hayashi, K.; Inokuchi, Y.; Tanabe, M.; Morita, J.; Nagasawa, S.; Kanematsu, K.; Yamada, T.; Ogata, T.; Oshima, T.; Miyagi, Y.; Yokose, T.; Machida, N.; Furuse, J. Share Save Safety, efficacy, and biomarkers for ONO-4578 plus nivolumab in unresectable advanced or recurrent gastric or gastroesophageal cancerHirano, H.; Kawazoe, A.; Yamaguchi, K.; Hamaguchi, T.; Narita, Y.; Boku, S.; Oshima, T.; Hara, H.; Hamamoto, Y.; Esaki, T.; Ishido, K. Share Save Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-585 studyShitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, YK.; Al-Batran, SE.; Yoshikawa, T.; Weber, P. E. Yanez; Di Bartolomeo, M.; Lonardi, S.; Fang, X.; Shih, CS.; Bhagia, P.; Bang, YJ. Share Save Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancerMimura, Kosaku; Ogata, Takashi; Yoshimoto, Yuya; Yoshida, Daisaku; Nakajima, Shotaro; Sato, Hisashi; Machida, Nozomu; Yamada, Takanobu; Watanabe, Yohei; Tamaki, Tomoaki; Fujikawa, Hirohito; Inokuchi, Yasuhiro; Hayase, Suguru; Hanayama, Hiroyuki; Saze, Zenichiro; Katoh, Hiroyuki; Takahashi, Fumiaki; Oshima, Takashi; Suzuki, Yoshiyuki; Kono, Koji Share Save Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective studyVeldhuizen, Gregory Patrick; Roecken, Christoph; Behrens, Hans-Michael; Cifci, Didem; Muti, Hannah Sophie; Yoshikawa, Takaki; Arai, Tomio; Oshima, Takashi; Tan, Patrick; Ebert, Matthias P.; Pearson, Alexander T.; Calderaro, Julien; Grabsch, Heike I.; Kather, Jakob Nikolas Share Save Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/TipiracilHashimoto, Itaru; Kano, Kazuki; Onuma, Shizune; Suematsu, Hideaki; Nagasawa, Shinsuke; Kanematsu, Kyohei; Furusawa, Kyoko; Hamaguchi, Tomomi; Watanabe, Mamoru; Hayashi, Kei; Furuta, Mitsuhiro; Inokuchi, Yasuhiro; Machida, Nozomu; Aoyama, Toru; Yamada, Takanobu; Rino, Yasushi; Ogata, Takashi; Oshima, Takashi Share Save Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after GastrectomyOnuma, Shizune; Hashimoto, Itaru; Suematsu, Hideaki; Nagasawa, Shinsuke; Kanematsu, Kyohei; Aoyama, Toru; Yamada, Takanobu; Rino, Yasushi; Ogata, Takashi; Oshima, Takashi Share Save Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?Kumazu, Yuta; Hasegawa, Shinichi; Hayashi, Tsutomu; Yamada, Takanobu; Watanabe, Hayato; Hara, Kentaro; Shimoda, Yota; Nakazono, Masato; Nagasawa, Shinsuke; Rino, Yasushi; Masuda, Munetaka; Ogata, Takashi; Oshima, Takashi; Yoshikawa, Takaki Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}